02:31:43 Europe / Stockholm

Prenumeration

2024-05-31 15:39:00

Redeye comments on the Q1 report 2024. The rest of 2024 is funded through the recent rights issue, including the readout of Verrica's phase II study that may change the investment case.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/